None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: . Patients who are willing to participate and sign the informed consent for this clinical trial. 2. Males and females between the age group of 20-40 years. 3. Periodontally healthy patients as assessed with a Plaque Index (Silness & Loe 1964) and Gingival Index (Loe & Silness 1963) between the score of 0â??1. 4. Patients with fully erupted well-aligned maxillary Central Incisors, Lateral Incisors and Canines without orthodontic anomaly.
Exclusion criteria
Exclusion criteria: . Artificial crowns, fillings, attrition on anterior teeth. 2. Congenitally missing anterior tooth or teeth. 3. Pregnancy or a history of taking medications known to increase the risk of gingival hyperplasia. 4. Patients diagnosed with destructive periodontal disease or hypertrophy. 5. Patients with a history of any periodontal treatment in the past six months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate and correlate the mesiodistal and faciopalatal horizontal and vertical dimensions of interproximal area with the presence of interdental papilla and gingival biotype in maxillary anterior teeth in periodontally healthy males and females.Timepoint: Baseline | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.To evaluate the mesiodistal and faciopalatal horizontal and vertical dimensions of interproximal area, presence or absence of interdental papillae, the gingival biotype, in maxillary anterior teeth in males and females. 2.To correlate the mesiodistal and faciopalatal horizontal and vertical dimensions of interproximal area with the presence of interdental papilla and gingival biotype in maxillary anterior teeth in males and females. Timepoint: Baseline | — |
Countries
India
Contacts
VSPM Dental College and Research Centre, Nagpur